We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

46 hedge funds and large institutions have $79M invested in Arcturus Therapeutics in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more call options, than puts

Call options by funds: $848K | Put options by funds: $369K

8% less funds holding

Funds holding: 50 → 46 (-4)

21% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 14

39% less capital invested

Capital invested by funds: $131M → $79M (-$51.5M)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
46
Holders Change
-4
Holders Change %
-8%
% of All Funds
1.23%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
5
Increased
11
Reduced
14
Closed
9
Calls
$848K
Puts
$369K
Net Calls
+$479K
Net Calls Change
+$430K

Top Buyers

1
Franklin Resources
Franklin Resources
California
+$3.89M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$235K
3
BFA
BlackRock Fund Advisors
California
+$175K
4
SM
Sabby Management
Florida
+$161K
5
VKH
Virtu KCG Holdings
New York
+$120K

Top Sellers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$2.13M
2
GTC
Ghost Tree Capital
New York
-$967K
3
FAM
Fred Alger Management
New York
-$547K
4
QSS
Quantitative Systematic Strategies
Florida
-$211K
5
Group One Trading
Group One Trading
Illinois
-$172K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
– -$22.9K -676 Closed
IA
52
IFP Advisors
Florida
– -$9K -214 Closed
LWA
53
Lenox Wealth Advisors
New York
– -$4K -86 Closed
Barclays
54
Barclays
United Kingdom
– -$1.15K -34 -49%
1 2
3

ARCT Hedge Fund Activity: Q1 2016 in Review

46 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q1 2016, worth a combined $79M — down 39% from $131M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ARCT and 5 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 11 added.

The largest buyer was Franklin Resources, adding an estimated $3.89M. The largest seller was Balyasny Asset Management, cutting an estimated $2.13M.

  • 46 institutional investors held Arcturus Therapeutics (ARCT) as of Q1 2016, down from 50 in Q4 2015.
  • Funds reported $79M of Arcturus Therapeutics stock for Q1 2016, down 39% quarter-over-quarter.
  • 5 funds opened new Arcturus Therapeutics positions in Q1 2016 and 9 closed out, a net change of -4 holders.
  • The largest Arcturus Therapeutics buyer in Q1 2016 was Franklin Resources, an estimated $3.89M added.
  • The largest Arcturus Therapeutics seller in Q1 2016 was Balyasny Asset Management, an estimated $2.13M sold.

Based on aggregated 13F filings for Q1 2016.